½ÃÀ庸°í¼­
»óǰÄÚµå
1334614

¼¼°èÀÇ ¿åâ ¿¹¹æ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Pressure Ulcer Prevention Market Size Study & Forecast, by Product Type, By End-User, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿åâ ¿¹¹æ ½ÃÀåÀº 2022³â ¾à 10¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 4.0% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿åâÀº ¿åâÀ̶ó°íµµ Çϸç, ÇǺο¡ Àå½Ã°£ ¾Ð·ÂÀÌ °¡ÇØÁ® ÇǺΰ¡ ¼Õ»óµÈ ºÎÀ§¸¦ ¸»ÇÕ´Ï´Ù. ¿åâÀº ½Åü ¾î´À ºÎÀ§¿¡¼­³ª ¹ß»ýÇÒ ¼ö ÀÖÁö¸¸ ¾ûµ¢ÀÌ, ÆÈ²ÞÄ¡, ¹ßµÚ²ÞÄ¡, ¾î±ú µî ºÎÀ§¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇÕ´Ï´Ù. ¿åâÀº ½É°¢ÇÑ ¹®Á¦À̸ç, °¨¿°°ú ÆÐÇ÷ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ°í, °æ¿ì¿¡ µû¶ó¼­´Â »ç¸Á¿¡ À̸¦ ¼öµµ ÀÖ½À´Ï´Ù. ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, »óóÀÇ Á¶±â ȸº¹¿¡ ´ëÇÑ °ü½É Áõ°¡, ÀÔ¿ø ȯÀÚÀÇ ¿åâ ±ÞÁõ, »õ·Î¿î ¿åâ ¿¹¹æ Á¦Ç°ÀÇ °³¹ß Áõ°¡´Â Àü ¼¼°èÀûÀ¸·Î ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¶ÇÇÑ °í·ÉÈ­·Î ÀÎÇØ COPD, ´ç´¢º´, ½ÅºÎÀü µî ¸¸¼ºÁúȯ¿¡ °É¸®±â ½±½À´Ï´Ù. ±× °á°ú ÀÔ¿ø ±â°£ÀÌ ±æ¾îÁö°í ³ëÀÎÀÇ Ã¼¾Ð »óÇØ°¡ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ¼¼°è ½ÃÀå ¹ßÀü¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¼­¿¡ µû¸£¸é ³ëÀÎ Àα¸´Â 2020³â 10¾ï ¸í¿¡¼­ 2030³â 15¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸ 6¸í Áß 1¸íÀÌ ³ëÀÎÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µû¶ó¼­ ºü¸£°Ô Áõ°¡ÇÏ´Â ³ëÀÎ Àα¸´Â ´Ù¾çÇÑ Áúº´¿¡ °É¸®±â ½¬¿ö ½ÃÀå ¼ºÀåÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿åâ ¿¹¹æ¿¡ ÀÖ¾î ÷´Ü ±â¼úÀÇ È°¿ëÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¿åâ ¿¹¹æÀ» À§ÇÑ Á¤ºÎÀÇ ³ë·ÂÀÌ Áõ°¡Çϰí ÀÖ´Â °Íµµ ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¿åâ ¿¹¹æ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú ¿åâ ¿¹¹æÀÇ º¹À⼺Àº 2023³âºÎÅÍ 2030³â±îÁö ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¿åâ ¿¹¹æ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ Àνİú Á߿伺ÀÌ ³ô¾ÆÁö°í ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ ±â¼ú ¹× Á¦Ç° Çõ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °³¹ß, °í·ÉÈ­ Àα¸ÀÇ Áõ°¡, Àå±â ¿ä¾ç ½Ã¼³ÀÇ Áõ°¡ µîÀÌ ÀÌ Áö¿ª Àüü ½ÃÀå ¼ö¿ä¸¦ Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â µ¿¾È ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â µ¿¾È ½ÃÀå °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¿åâ ¿¹¹æ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°èÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¿åâ ¿¹¹æ ½ÃÀå ¿ªÇÐ

  • ¿åâ ¿¹¹æ ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • º´¿ø ÀÔ¿ø ȯÀÚÀÇ ¿åâ À¯º´·ü Áõ°¡
      • ³ëÀÎ Àα¸ Áõ°¡
    • ½ÃÀå °úÁ¦
      • ¿åâ ¿¹¹æ °ü·Ã °íºñ¿ë
      • ¿åâ ¿¹¹æÀÇ º¹À⼺
    • ½ÃÀå ±âȸ
      • ¿åâ ¿¹¹æÀÇ Ã·´Ü ±â¼ú ÀÌ¿ë ±ÞÁõ
      • ¿åâ ¿¹¹æÀ» ÃßÁøÇÏ´Â Á¤ºÎ Á¤Ã¥ Áõ°¡

Á¦4Àå ¼¼°èÀÇ ¿åâ ¿¹¹æ ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº°

  • ½ÃÀå ÇöȲ
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : Á¦Ç° À¯Çüº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Á¤Àû ¼­Æ÷Æ® ¼­Çǽº
    • µ¿Àû ¼­Æ÷Æ® ¼­Çǽº
    • µå·¹½Ì
    • Æ÷Áö¼Å³Ê¡¤ÇÁ·ÎÅØÅÍ
    • Å©¸²¡¤±âŸ

Á¦6Àå ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø¡¤¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
    • Ŭ¸®´Ð
    • Àå±â Äɾ±ä±Þ ÀÇ·á ¼¾ÅÍ
    • ÀçÅà Äɾî ȯ°æ
    • ±âŸ

Á¦7Àå ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¿åâ ¿¹¹æ ¼¼°è ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´ÀÇ ¿åâ ¿¹¹æ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿åâ ¿¹¹æ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ¿åâ ¿¹¹æ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Agiliti Health, Inc.(U.S.)
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±ÙÀÇ µ¿Çâ
    • Arjo(Sweden)
    • Savaria(Canada)
    • Medline Industries, LP(U.S.)
    • Coloplast Corp.(Denmark)
    • Smith & Nephew plc(U.K.)
    • Stryker(U.S.)
    • Molnlycke Health Care AB(Sweden)
    • Hill-Rom Holdings, Inc.(U.S.)
    • Invacare Corporation(U.S.)

Á¦9Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 23.09.19

Global Pressure Ulcer Prevention Market is valued at approximately USD 1.04 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.0% over the forecast period 2023-2030. Pressure ulcers, also known as bedsores, are areas of damaged skin that develop when pressure is applied to the skin for a long period of time. Pressure ulcers occur anywhere on the body, but they are most common in parts such as the hips, elbows, heels, and shoulders. Pressure ulcers are considered a serious problem and they may result in infection, sepsis, and in a few cases death. The increasing prevalence of chronic diseases, growing focus on the faster recovery of wounds, surge in the prevalence of pressure ulcers in hospital inpatient settings, and rising development of new pressure ulcer prevention products are the key factors that are propelling the market growth across the globe.

Additionally, the aging population is more vulnerable to chronic diseases like COPD, diabetes, and renal failure. This leads to prolonged hospitalization, which results in pressure injuries in the elderly population. Accordingly, the increasing geriatric population is exhibiting a positive influence on the market development globally. The World Health Organization (WHO) reported that it is anticipated that the number of aging people increase from 1 billion in 2020 to 1.5 billion in 2030 which worldwide accounts for 1 in 6 people above 60. Hence, the rapidly growing geriatric population is more prone to be affected by a range of diseases, which is creating lucrative opportunities for market growth. Furthermore, the surging use of advanced technologies in the prevention of pressure ulcers, as well as the increasing government initiatives to promote pressure ulcer prevention present various lucrative opportunities over the forecasting years. However, the high costs associated with pressure ulcer prevention and the complexity of pressure ulcer prevention are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pressure Ulcer Prevention Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the growing awareness and emphasis on patient safety, as well as increasing advancements in technology and product innovation by the key market players Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The increasing government initiatives, development of the healthcare infrastructure, as well as rising aging population and long-term care facilities are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Agiliti Health, Inc. (U.S.)
  • Arjo (Sweden)
  • Savaria (Canada)
  • Medline Industries, LP (U.S.)
  • Coloplast Corp. (Denmark)
  • Smith & Nephew plc (U.K.)
  • Stryker (U.S.)
  • Molnlycke Health Care AB (Sweden)
  • Hill-Rom Holdings, Inc. (U.S.)
  • Invacare Corporation (U.S.)

Recent Developments in the Market:

  • In June 2022, Medline introduced its Optifoam Gentle EX foam dressing in order to avoid pressure injuries. This enabled the company to further diversify its product offering.
  • In January 2022, Invacare Corporation updated its LiNX electronics system by introducing widespread MK6 features. This facilitates user control via the LiNX system, making using a power wheelchair easier for users.
  • In July 2022, Medline Industries, LP launched the new version of the Optifoam Gentle EX foam dressing, which helps to minimize pressure injuries and aims on strengthening the company's product portfolio.

Global Pressure Ulcer Prevention Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product Type, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

  • Static Support Surfaces
  • Dynamic Support Surfaces
  • Dressings
  • Positioners & Protectors
  • Creams & Others

By End-User:

  • Hospitals & Ambulatory Surgery Centers
  • Clinics
  • Long Term Care & Urgent Care Centers
  • Homecare Settings
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Pressure Ulcer Prevention Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Pressure Ulcer Prevention Market, by Product Type, 2020-2030 (USD Billion)
    • 1.2.3. Pressure Ulcer Prevention Market, by End-User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pressure Ulcer Prevention Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pressure Ulcer Prevention Market Dynamics

  • 3.1. Pressure Ulcer Prevention Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of pressure ulcers in hospital inpatient settings
      • 3.1.1.2. Rising geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. High costs associated with pressure ulcer prevention
      • 3.1.2.2. Complexity of pressure ulcer prevention
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Surging use of advanced technologies in the prevention of pressure ulcers
      • 3.1.3.2. Increasing government initiatives to promote pressure ulcer prevention

Chapter 4. Global Pressure Ulcer Prevention Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Pressure Ulcer Prevention Market, by Product Type

  • 5.1. Market Snapshot
  • 5.2. Global Pressure Ulcer Prevention Market by Product Type, Performance - Potential Analysis
  • 5.3. Global Pressure Ulcer Prevention Market Estimates & Forecasts by Product Type 2020-2030 (USD Billion)
  • 5.4. Pressure Ulcer Prevention Market, Sub Segment Analysis
    • 5.4.1. Static Support Surfaces
    • 5.4.2. Dynamic Support Surfaces
    • 5.4.3. Dressings
    • 5.4.4. Positioners & Protectors
    • 5.4.5. Creams & Others

Chapter 6. Global Pressure Ulcer Prevention Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Pressure Ulcer Prevention Market by End-User, Performance - Potential Analysis
  • 6.3. Global Pressure Ulcer Prevention Market Estimates & Forecasts by End-User 2020-2030 (USD Billion)
  • 6.4. Pressure Ulcer Prevention Market, Sub Segment Analysis
    • 6.4.1. Hospitals & Ambulatory Surgery Centers
    • 6.4.2. Clinics
    • 6.4.3. Long Term Care & Urgent Care Centers
    • 6.4.4. Homecare Settings
    • 6.4.5. Others

Chapter 7. Global Pressure Ulcer Prevention Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Pressure Ulcer Prevention Market, Regional Market Snapshot
  • 7.4. North America Pressure Ulcer Prevention Market
    • 7.4.1. U.S. Pressure Ulcer Prevention Market
      • 7.4.1.1. Product Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End-User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Pressure Ulcer Prevention Market
  • 7.5. Europe Pressure Ulcer Prevention Market Snapshot
    • 7.5.1. U.K. Pressure Ulcer Prevention Market
    • 7.5.2. Germany Pressure Ulcer Prevention Market
    • 7.5.3. France Pressure Ulcer Prevention Market
    • 7.5.4. Spain Pressure Ulcer Prevention Market
    • 7.5.5. Italy Pressure Ulcer Prevention Market
    • 7.5.6. Rest of Europe Pressure Ulcer Prevention Market
  • 7.6. Asia-Pacific Pressure Ulcer Prevention Market Snapshot
    • 7.6.1. China Pressure Ulcer Prevention Market
    • 7.6.2. India Pressure Ulcer Prevention Market
    • 7.6.3. Japan Pressure Ulcer Prevention Market
    • 7.6.4. Australia Pressure Ulcer Prevention Market
    • 7.6.5. South Korea Pressure Ulcer Prevention Market
    • 7.6.6. Rest of Asia Pacific Pressure Ulcer Prevention Market
  • 7.7. Latin America Pressure Ulcer Prevention Market Snapshot
    • 7.7.1. Brazil Pressure Ulcer Prevention Market
    • 7.7.2. Mexico Pressure Ulcer Prevention Market
  • 7.8. Middle East & Africa Pressure Ulcer Prevention Market
    • 7.8.1. Saudi Arabia Pressure Ulcer Prevention Market
    • 7.8.2. South Africa Pressure Ulcer Prevention Market
    • 7.8.3. Rest of Middle East & Africa Pressure Ulcer Prevention Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Agiliti Health, Inc. (U.S.)
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Arjo (Sweden)
    • 8.3.3. Savaria (Canada)
    • 8.3.4. Medline Industries, LP (U.S.)
    • 8.3.5. Coloplast Corp. (Denmark)
    • 8.3.6. Smith & Nephew plc (U.K.)
    • 8.3.7. Stryker (U.S.)
    • 8.3.8. Molnlycke Health Care AB (Sweden)
    • 8.3.9. Hill-Rom Holdings, Inc. (U.S.)
    • 8.3.10. Invacare Corporation (U.S.)

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦